These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35818434)

  • 1. Understanding Physicians' Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach.
    Qu H; Silverman SL; Shewchuk RM; Curtis JR; Austin S; Greenspan SL; Nieves JW; Outman RC; Warriner AH; Watts NB; Saag KG
    Risk Manag Healthc Policy; 2022; 15():1293-1302. PubMed ID: 35818434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive mapping tobacco control advice for dentistry: a dental PBRN study.
    Qu H; Houston TK; Williams JH; Gilbert GH; Shewchuk RM;
    Am J Health Behav; 2011; 35(2):228-39. PubMed ID: 21204685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: An analysis of patient perceptions.
    Orimo H; Sato M; Kimura S; Wada K; Chen X; Yoshida S; Crawford B
    Osteoporos Sarcopenia; 2017 Dec; 3(4):174-184. PubMed ID: 30775527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
    Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
    Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context.
    Qu H; Shewchuk RM; Alarcón G; Fraenkel L; Leong A; Dall'Era M; Yazdany J; Singh JA
    Arthritis Care Res (Hoboken); 2016 Dec; 68(12):1787-1794. PubMed ID: 27059939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do osteoporosis patients perceive their illness and treatment? Implications for clinical practice.
    Besser SJ; Anderson JE; Weinman J
    Arch Osteoporos; 2012; 7():115-24. PubMed ID: 23225289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness about barriers to medication adherence in cardiovascular patients and strategies used in clinical practice by Portuguese clinicians: a nationwide study.
    Aguiar J; Ribeiro M; Pedro AR; Martins AP; da Costa FA
    Int J Clin Pharm; 2021 Jun; 43(3):629-636. PubMed ID: 33104948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis medication adherence: physician perceptions vs. patients' utilization.
    Curtis JR; Cai Q; Wade SW; Stolshek BS; Adams JL; Balasubramanian A; Viswanathan HN; Kallich JD
    Bone; 2013 Jul; 55(1):1-6. PubMed ID: 23502042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to Medication Decision Making in Women with Lupus Nephritis: A Formative Study using Nominal Group Technique.
    Singh JA; Qu H; Yazdany J; Chatham W; Dall'era M; Shewchuk RM
    J Rheumatol; 2015 Sep; 42(9):1616-23. PubMed ID: 26178276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study in the Asia-Pacific Region (MUSIC OS-AP): Design of a multinational, prospective, observational study examining the impact of gastrointestinal events on osteoporosis management in postmenopausal women.
    Modi A; Ebeling PR; Lee MS; Min YK; Mithal A; Yang X; Sajjan S
    Bone Rep; 2015 Dec; 3():61-66. PubMed ID: 28377968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy's fracture clinic screening program.
    Beaton DE; Dyer S; Jiang D; Sujic R; Slater M; Sale JE; Bogoch ER;
    Osteoporos Int; 2014 Jan; 25(1):289-96. PubMed ID: 23794044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for Not Treating Women with Postmenopausal Osteoporosis with Prescription Medications: Physicians' and Patients' Perspectives.
    Weaver JP; Olsson K; Sadasivan R; Modi A; Sen S
    J Womens Health (Larchmt); 2017 Dec; 26(12):1302-1311. PubMed ID: 28994642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Roux S; Gaboury I; Gionet-Landry N; Garant MP; Beaulieu MC; Carrier N; Cabana F; Boire G
    Osteoporos Int; 2018 Apr; 29(4):961-971. PubMed ID: 29445831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Side Effects, Physician Involvement, and Patient Perception in Non-Adherence with Oral Bisphosphonates.
    Goldshtein I; Rouach V; Shamir-Stein N; Yu J; Chodick G
    Adv Ther; 2016 Aug; 33(8):1374-84. PubMed ID: 27329383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis.
    Liu J; Guo H; Rai P; Pinto L; Barron R
    Osteoporos Int; 2018 Nov; 29(11):2409-2417. PubMed ID: 30022254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older women's views about prescription osteoporosis medication: a cross-sectional, qualitative study.
    Mazor KM; Velten S; Andrade SE; Yood RA
    Drugs Aging; 2010 Dec; 27(12):999-1008. PubMed ID: 21087069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirming the theoretical structure of expert-developed text messages to improve adherence to anti-hypertensive medications.
    Farris KB; Salgado TM; Batra P; Piette JD; Singh S; Guhad A; Newman S; Marshall VD; An L
    Res Social Adm Pharm; 2016; 12(4):578-91. PubMed ID: 26525857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women.
    Lau E; Papaioannou A; Dolovich L; Adachi J; Sawka AM; Burns S; Nair K; Pathak A
    Can Fam Physician; 2008 Mar; 54(3):394-402. PubMed ID: 18337534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study.
    Lukert B; Satram-Hoang S; Wade S; Anthony M; Gao G; Downs R
    Drugs Aging; 2011 Sep; 28(9):713-27. PubMed ID: 21913737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.